# Crofelemer for Functional Diarrhea

> **NCT04486326** · PHASE4 · TERMINATED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **DRUG:** Crofelemer
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04486326
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-20
- **Primary completion:** 2022-09-23
- **Final completion:** 2022-09-23
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04486326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04486326, "Crofelemer for Functional Diarrhea". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04486326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*